(Q43495480)

English

Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model

scientific article published in January 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation model (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

Nick Freemantle

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Guiqing Yao

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Marcus Flather

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Puvan Tharmanathan

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Andrew Coats

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Philip A Poole-Wilson

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

SENIORS Investigators

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

879-889

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

The epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200826100-00007

21 January 2018

A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The epidemiology of heart failure: the Framingham Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hospitalization of patients with heart failure: a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacotherapy for people with Alzheimer's disease: a Markov-cycle evaluation of five years' therapy using donepezil

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of benazepril in chronic renal insufficiency.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling in the economic evaluation of health care: selecting the appropriate approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Handling uncertainty in cost-effectiveness models

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of beta-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness results from the US Carvedilol Heart Failure Trials Program

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The current cost of heart failure to the National Health Service in the UK.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markov models in medical decision making: a practical guide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic effects of beta-blocker therapy in patients with heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of carvedilol for heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A taxonomy of model structures for economic evaluation of health technologies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18793034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200826100-00007

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43495480&oldid=2206079415"